Dongsung Pharmaceutical Decides to Cancel 250,000 Common Shares Under Rehabilitation Plan
For debt restructuring, 250,000 common shares held by Lee (all) will be cancelled without compensation; cancellation date is May 14, 2026.
This capital reduction is an implementation measure under the rehabilitation plan approved by Seoul Bankruptcy Court (March 27, 2026); no need for shareholder meeting or board resolution.
The company plans to sequentially issue convertible bonds and corporate bonds upon court approval.
KOSPI Filing Information
Filing: [Correction of Description] Report on Major Matters (Decision on Capital Reduction)